Repurposing of lonafarnib as a treatment for SARS-CoV-2 infection.
Khan M, Irvin P, Park SB, Ivester HM, Ricardo-Lax I, Leek M, Grieshaber A, Jang ES, Coutermarsh-Ott S, Zhang Q, Maio N, Jiang JK, Li B, Huang W, Wang AQ, Xu X, Hu Z, Zheng W, Ye Y, Rouault T, Rice C, Allen IC, Liang TJ.
Khan M, et al. Among authors: liang tj.
JCI Insight. 2025 Jan 9;10(1):e182704. doi: 10.1172/jci.insight.182704.
JCI Insight. 2025.
PMID: 39625789
Free PMC article.